Prednisone Completed Phase 1 / 2 Trials for Malignancies / Castrate-resistant Prostate Cancer (CRPC) / Mestastatic Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01385228Pazopanib, Docetaxel, Prednisone Prostate
NCT01378091Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer